$100 mil­lion in­vest­ment into can­cer treat­ment

Daily Mercury - - NEWS -

IN A rich an­nounce­ment for can­cer pa­tients in need of fi­nan­cial help, the Fed­eral Gov­ern­ment has in­vested $100 mil­lion into the Phar­ma­ceu­ti­cal Ben­e­fits Scheme which will add five new can­cer list­ings and treat­ments.

The un­veil­ing of a host of med­i­ca­tions added to the PBS will en­sure pa­tients are af­forded more ac­ces­si­ble op­tions to treat­ments of var­i­ous can­cers; in­clud­ing ma­lig­nant melanomas that can­not be sur­gi­cally re­moved and acute myeloid leukaemia.

Mem­ber for Daw­son Ge­orge Chris­tensen praised the in­vest­ment, and said pa­tients would now be pro­vided ac­cess to “life­sav­ing and life-chang­ing medicines quicker than ever be­fore”.

“From De­cem­ber 1, el­i­gi­ble pa­tients through­out the re­gion with cer­tain forms of leukaemia, ad­vanced tu­mours of the in­tes­tine and pan­creas, melanoma, bowel can­cer and ovar­ian can­cer will save up to $100,000 a year.”

This Oc­to­ber a re­port by the De­part­ment of Health stated that melanoma rates in Queens­land were the high­est in the coun­try, see­ing a 13 per cent in­crease among adults aged 45 to 64.

The com­bi­na­tion of med­i­ca­tions known as Op­divo and Yer­voy ad­dresses a high and un­met clin­i­cal need for this de­bil­i­tat­ing con­di­tion, ac­cord­ing to the Phar­ma­ceu­ti­cal Ben­e­fits Ad­vi­sory Com­mit­tee.

The col­lab­o­ra­tion of the treat­ments may im­prove out­comes for pa­tients, with costs ex­ceed­ing $100,000 a course.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.